KNApSAcK Metabolite C00049664
Metabolite
KNApSAcK Entry
| id | C00049664 |
|---|---|
| Name | Pregnenolone |
| CAS RN | 145-13-1 |
| Standard InChI | InChI=1S/C21H32O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4,15-19,23H,5-12H2,1-3H3/t15-,16-,17+,18-,19-,20-,21+/m0/s1 |
| Standard InChI (Main Layer) | InChI=1S/C21H32O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4,15-19,23H,5-12H2,1-3H3 |
Cluster
| Phytochemical cluster | |
|---|---|
| KCF-S cluster | No. 1223 |
Link
ChEMBL
| By standard InChI | CHEMBL253363 |
|---|---|
| By standard InChI Main Layer | CHEMBL77462 CHEMBL383839 CHEMBL253363 CHEMBL1435695 CHEMBL1455777 |
KEGG
| By LinkDB | C01953 |
|---|
CTD
| By CAS RN | D011284 |
|---|
Species
Summary
List (1)
* NCBI
| KNApSAcK organism | *ID | *family | *plant class | *kingdom |
|---|---|---|---|---|
| Zanthoxylum integrifoliolum | 67937 | Rutaceae | rosids | Viridiplantae |
Human Protein / Gene in interaction
22 ChEMBL Protein in interactions
| accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|---|
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL1435695 |
CHEMBL1741321
(1)
|
1 / 0 |
| P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | CHEMBL253363 |
CHEMBL1908082
(1)
|
3 / 0 |
| O75795 | UDP-glucuronosyltransferase 2B17 | Enzyme | CHEMBL253363 |
CHEMBL1908091
(2)
|
1 / 0 |
| O00204 | Sulfotransferase family cytosolic 2B member 1 | Enzyme | CHEMBL253363 |
CHEMBL1743311
(1)
|
0 / 0 |
| Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | CHEMBL253363 |
CHEMBL1908087
(1)
|
0 / 0 |
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | CHEMBL253363 |
CHEMBL1794499
(1)
|
2 / 0 |
| P02545 | Prelamin-A/C | Unclassified protein | CHEMBL253363 CHEMBL1435695 |
CHEMBL1614544
(2)
|
11 / 10 |
| Q16850 | Lanosterol 14-alpha demethylase | Cytochrome P450 51A1 | CHEMBL253363 |
CHEMBL934981
(1)
|
0 / 0 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL1435695 |
CHEMBL1741325
(1)
|
0 / 1 |
| P16662 | UDP-glucuronosyltransferase 2B7 | Enzyme | CHEMBL253363 |
CHEMBL1908093
(1)
|
0 / 0 |
| Q06520 | Bile salt sulfotransferase | Enzyme | CHEMBL253363 |
CHEMBL1743310
(1)
|
0 / 0 |
| P04278 | Sex hormone-binding globulin | Secreted protein | CHEMBL253363 |
CHEMBL812631
(1)
CHEMBL858260
(1)
CHEMBL809266 (1) CHEMBL809276 (1) CHEMBL858262 (1) CHEMBL922711 (1) |
0 / 0 |
| P11413 | Glucose-6-phosphate 1-dehydrogenase | Enzyme | CHEMBL253363 |
CHEMBL2061901
(1)
|
1 / 2 |
| P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | CHEMBL253363 |
CHEMBL2114810
(1)
|
7 / 3 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL1435695 |
CHEMBL1741322
(1)
|
0 / 0 |
| Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | CHEMBL253363 |
CHEMBL1908085
(2)
|
0 / 0 |
| P08185 | Corticosteroid-binding globulin | Secreted protein | CHEMBL253363 |
CHEMBL665988
(1)
CHEMBL665989
(1)
CHEMBL665992 (1) CHEMBL665994 (1) CHEMBL665995 (1) CHEMBL840929 (1) CHEMBL665996 (1) CHEMBL665997 (1) CHEMBL858261 (1) |
1 / 1 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL1435695 |
CHEMBL1741323
(1)
|
1 / 1 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL1435695 |
CHEMBL1741324
(1)
|
0 / 1 |
| Q9UNA4 | DNA polymerase iota | Enzyme | CHEMBL77462 |
CHEMBL1794483
(1)
|
0 / 0 |
| P49888 | Estrogen sulfotransferase | Enzyme | CHEMBL253363 |
CHEMBL1743309
(1)
|
0 / 0 |
| P56937 | 3-keto-steroid reductase | Enzyme | CHEMBL253363 |
CHEMBL1106724
(1)
CHEMBL1106725
(1)
|
0 / 0 |
CTD interaction (16)
| compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
|---|---|---|---|---|---|---|---|
| D011284 | 1583 |
CYP11A1
CYP11A CYPXIA1 P450SCC |
cytochrome P450, family 11, subfamily A, polypeptide 1 (EC:1.14.15.6) | CYP11A1 protein results in increased chemical synthesis of Pregnenolone |
increases chemical synthesis
|
protein |
16054388
19900470 |
| D011284 | 1586 |
CYP17A1
CPT7 CYP17 P450C17 S17AH |
cytochrome P450, family 17, subfamily A, polypeptide 1 (EC:1.14.99.9 4.1.2.30) | CYP17A1 protein affects the metabolism of Pregnenolone |
affects metabolic processing
|
protein |
16030167
16054388 |
| D011284 | 1586 |
CYP17A1
CPT7 CYP17 P450C17 S17AH |
cytochrome P450, family 17, subfamily A, polypeptide 1 (EC:1.14.99.9 4.1.2.30) | CYP17A1 protein mutant form results in increased hydroxylation of Pregnenolone |
increases hydroxylation
|
protein |
15844475
|
| D011284 | 1586 |
CYP17A1
CPT7 CYP17 P450C17 S17AH |
cytochrome P450, family 17, subfamily A, polypeptide 1 (EC:1.14.99.9 4.1.2.30) | CYP17A1 protein results in increased hydroxylation of Pregnenolone |
increases hydroxylation
|
protein |
15562394
15844475 |
| D011284 | 1576 |
CYP3A4
CP33 CP34 CYP3A CYP3A3 CYPIIIA3 CYPIIIA4 HLP NF-25 P450C3 P450PCN1 |
cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) | Pregnenolone results in increased expression of CYP3A4 mRNA |
increases expression
|
mRNA |
15650019
|
| D011284 | 1576 |
CYP3A4
CP33 CP34 CYP3A CYP3A3 CYPIIIA3 CYPIIIA4 HLP NF-25 P450C3 P450PCN1 |
cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) | Pregnenolone results in increased expression of CYP3A4 protein |
increases expression
|
protein |
15650019
|
| D011284 | 2254 |
FGF9
FGF-9 GAF HBFG-9 HBGF-9 SYNS3 |
fibroblast growth factor 9 | FGF9 protein inhibits the reaction [[FSHB protein co-treated with IGF1 protein co-treated with trilostane] results in increased abundance of Pregnenolone] |
affects cotreatment
/ decreases reaction / increases abundance |
protein |
22798350
|
| D011284 | 2488 |
FSHB
|
follicle stimulating hormone, beta polypeptide | FGF9 protein inhibits the reaction [[FSHB protein co-treated with IGF1 protein co-treated with trilostane] results in increased abundance of Pregnenolone] |
affects cotreatment
/ decreases reaction / increases abundance |
protein |
22798350
|
| D011284 | 2488 |
FSHB
|
follicle stimulating hormone, beta polypeptide | [FSHB protein co-treated with IGF1 protein co-treated with trilostane] results in increased abundance of Pregnenolone |
affects cotreatment
/ increases abundance |
protein |
22798350
|
| D011284 | 3156 |
HMGCR
LDLCQ3 |
3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) | Pregnenolone inhibits the reaction [25-hydroxycholesterol results in decreased activity of HMGCR protein] |
decreases activity
/ decreases reaction |
protein |
9059514
|
| D011284 | 3156 |
HMGCR
LDLCQ3 |
3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) | Pregnenolone inhibits the reaction [27-hydroxycholesterol results in decreased activity of HMGCR protein] |
decreases activity
/ decreases reaction |
protein |
9059514
|
| D011284 | 3283 |
HSD3B1
3BETAHSD HSD3B HSDB3 HSDB3A I SDR11E1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 (EC:1.1.1.145 5.3.3.1) | HSD3B1 protein affects the metabolism of Pregnenolone |
affects metabolic processing
|
protein |
16054388
|
| D011284 | 3479 |
IGF1
IGF-I IGF1A IGFI |
insulin-like growth factor 1 (somatomedin C) | FGF9 protein inhibits the reaction [[FSHB protein co-treated with IGF1 protein co-treated with trilostane] results in increased abundance of Pregnenolone] |
affects cotreatment
/ decreases reaction / increases abundance |
protein |
22798350
|
| D011284 | 3479 |
IGF1
IGF-I IGF1A IGFI |
insulin-like growth factor 1 (somatomedin C) | [FSHB protein co-treated with IGF1 protein co-treated with trilostane] results in increased abundance of Pregnenolone |
affects cotreatment
/ increases abundance |
protein |
22798350
|
| D011284 | 8856 |
NR1I2
BXR ONR1 PAR PAR1 PAR2 PARq PRR PXR SAR SXR |
nuclear receptor subfamily 1, group I, member 2 | Pregnenolone binds to and results in increased activity of NR1I2 protein |
affects binding
/ increases activity |
protein |
16054614
|
| D011284 | 8856 |
NR1I2
BXR ONR1 PAR PAR1 PAR2 PARq PRR PXR SAR SXR |
nuclear receptor subfamily 1, group I, member 2 | Pregnenolone results in increased activity of NR1I2 protein |
increases activity
|
protein |
15650019
|
Related Disease
Diseases related to proteins in ChEMBL interactions
OMIM (28)
| OMIM | preferred title | UniProt |
|---|---|---|
| #219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
| #300908 | Anemia, nonspherocytic hemolytic, due to g6pd deficiency |
P11413
|
| #612560 | Bone mineral density quantitative trait locus 12; bmnd12 |
O75795
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #611489 | Corticosteroid-binding globulin deficiency |
P08185
|
| #218800 | Crigler-najjar syndrome, type i |
P22310
|
| #606785 | Crigler-najjar syndrome, type ii |
P22310
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #143500 | Gilbert syndrome |
P22310
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| #174800 | Mccune-albright syndrome; mas |
P63092
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #166350 | Osseous heteroplasia, progressive; poh |
P63092
|
| #102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
| #103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
| #603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
| #612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #604906 | Schizophrenia 9; sczd9 |
P49798
|
| #181500 | Schizophrenia; sczd |
P49798
|
KEGG DISEASE (19)
| KEGG | disease name | UniProt |
|---|---|---|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H01163 | Corticosteroid-binding globulin (CBG) deficiency |
P08185
(related)
|
| H00036 | Osteosarcoma |
P08684
(marker)
|
| H00101 | Other phagocyte defects |
P11413
(related)
|
| H00668 | Anemia due to disorders of glutathione metabolism |
P11413
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
| H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
| H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|